iifl-logo

Lincoln Pharmaceuticals Ltd Share Price

556.65
(-3.04%)
Apr 4, 2025|01:04:57 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open578.95
  • Day's High579.1
  • 52 Wk High979.5
  • Prev. Close574.1
  • Day's Low556
  • 52 Wk Low 499
  • Turnover (lac)233.86
  • P/E12.88
  • Face Value10
  • Book Value331.31
  • EPS44.62
  • Mkt. Cap (Cr.)1,114.95
  • Div. Yield0.31
View All Historical Data
No Records Found

Lincoln Pharmaceuticals Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

578.95

Prev. Close

574.1

Turnover(Lac.)

233.86

Day's High

579.1

Day's Low

556

52 Week's High

979.5

52 Week's Low

499

Book Value

331.31

Face Value

10

Mkt Cap (₹ Cr.)

1,114.95

P/E

12.88

EPS

44.62

Divi. Yield

0.31

Lincoln Pharmaceuticals Ltd Corporate Action

5 Feb 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

2 Sep 2024

12:00 AM

AGM

Announcement Date: 02 Sep, 2024

arrow

2 Sep 2024

12:00 AM

BookCloser

arrow

16 May 2024

12:00 AM

Dividend

Dividend Amount: 1.8

arrow

Lincoln Pharmaceuticals Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Lincoln Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT

04 Apr, 2025|01:41 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 49.77%

Foreign: 0.00%

Indian: 49.77%

Non-Promoter- 5.16%

Institutions: 5.16%

Non-Institutions: 45.06%

Custodian: 0.00%

Share Price

Lincoln Pharmaceuticals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

20.03

20.03

20.03

20.03

Preference Capital

0

0

0

0

Reserves

572.81

482.44

412.85

346.36

Net Worth

592.84

502.47

432.88

366.39

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2020Mar-2018Mar-2017Mar-2016

Revenue

376.08

324.95

304.27

310.81

yoy growth (%)

15.73

6.79

-2.1

39.21

Raw materials

-186.77

-171.16

-172.67

-203.65

As % of sales

49.66

52.67

56.74

65.52

Employee costs

-54.89

-47.5

-35.05

-26.73

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2020Mar-2018Mar-2017Mar-2016

Profit before tax

64.04

43.09

35.74

30.05

Depreciation

-5.46

-4.39

-3.85

-3.21

Tax paid

-14.48

-10.34

-8.33

-8.31

Working capital

-8.51

25.15

13.34

-4.84

Other operating items

View Cash Flow
Y/e 31 MarMar-2020Mar-2018Mar-2017Mar-2016

Growth matrix (%)

Revenue growth

15.73

6.79

-2.1

39.21

Op profit growth

29.17

8

30.85

40.73

EBIT growth

39.41

15.08

15.61

39.5

Net profit growth

51.3

19.53

26.01

47.2

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

580.55

510.31

472.12

424.19

386.49

Excise Duty

0

0

0

0

0

Net Sales

580.55

510.31

472.12

424.19

386.49

Other Operating Income

0

0

0

0

0

Other Income

34.42

22.47

10

5.66

11.04

Lincoln Pharmaceuticals Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,770

134.814,24,706.281,181.050.765,985.3398.33

Divis Laboratories Ltd

DIVISLAB

5,763

73.781,52,945.745940.522,297513.62

Cipla Ltd

CIPLA

1,495.7

25.941,20,750.871,438.150.874,134.87360.73

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,247.7

60.291,09,983.064850.862,330222.38

Mankind Pharma Ltd

MANKIND

2,427.7

51.81,00,167.88416.3802,396.57334.17

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Lincoln Pharmaceuticals Ltd

Management

Register Office

Registrar Office

Chairman (Non-Executive)

Kishorbhai M Shah

Managing Director

Mahendra G Patel

Whole-time Director

Hasmukhbhai I Patel

Whole-time Director

Munjal Mahendrabhai Patel

Whole-time Director

Aashish R Patel

Independent Director

Saurin J Parikh

Non Executive Director

Rajnikant G Patel

Company Sec. & Compli. Officer

Trusha Shah

Independent Director

Seema Mehta

Independent Director

Nareshkumar Pirabhai Suthar

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Lincoln Pharmaceuticals Limited, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a Partnership Firm in January, 1979 to manufacture pharmaceutical formulations was converted into a Public Limited Company in Jan. 95. All the assets and business of the erstwhile partnership were transferred to the Company. The Company is engaged in the business of manufacturing and trading of pharmaceutical products. The focused area includes anti-infective, respiratory system, gynecology, cardio & CNS, anti-diabetic, anti malaria, among others.The Company, incorporated in January, 1995, was carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982. It then set up its own manufacturing facilities at Naroda, Gujarat for manufacturing tablets, capsules, liquid and powder syrups and, ointments. It is also getting its products manufactured on loan licence basis from other manufacturers to meet the demand of small volume parenterals.The company has set up a modern formulation manufacturing plant at Khatraj (Mehsana district), Gujarat, to manufacture small volume parenterals like dry powder injectables, liquid vial, liquid ampoules and eye drops and expand its production capacities of the existing products. It is also in the process of establishing a fully equipped laboratory to undertake in-house testing of its products for better quality control and R&D. It came out with a public issue in Feb.96 to part-finance its project.The
Read More

Company FAQs

What is the Lincoln Pharmaceuticals Ltd share price today?

The Lincoln Pharmaceuticals Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹556.65 today.

What is the Market Cap of Lincoln Pharmaceuticals Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Lincoln Pharmaceuticals Ltd is ₹1114.95 Cr. as of 04 Apr ‘25

What is the PE and PB ratio of Lincoln Pharmaceuticals Ltd?

The PE and PB ratios of Lincoln Pharmaceuticals Ltd is 12.88 and 1.80 as of 04 Apr ‘25

What is the 52 Week High and Low of Lincoln Pharmaceuticals Ltd?

The 52-week high/low is the highest and lowest price at which a Lincoln Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Lincoln Pharmaceuticals Ltd is ₹499 and ₹979.5 as of 04 Apr ‘25

What is the CAGR of Lincoln Pharmaceuticals Ltd?

Lincoln Pharmaceuticals Ltd's CAGR for 5 Years at 36.79%, 3 Years at 20.06%, 1 Year at -5.96%, 6 Month at -14.93%, 3 Month at -32.82% and 1 Month at 6.02%.

What is the shareholding pattern of Lincoln Pharmaceuticals Ltd?

The shareholding pattern of Lincoln Pharmaceuticals Ltd is as follows:
Promoters - 49.78 %
Institutions - 5.16 %
Public - 45.06 %

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.